PEPTO RELIEF- bismuth subsalicylate tablet, chewable
Advance Pharmaceutical Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Do not take if you are
Do not use
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are
when using this product a temporary, but harmless, darkening of the stool and/or tongue may occur
stop use and ask a doctor if
diarrhea lasts more than 2 days
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
calcium carbonate, D&C red # 27 (Al-lake), dextrose, flavor (cherry), magnesium stearate, maltodextrin, silicon dioxide, sorbitol
PEPTO RELIEF
bismuth subsalicylate tablet, chewable |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Advance Pharmaceutical Inc. (078301063) |
Registrant - Advance Pharmaceutical Inc. (078301063) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Advance Pharmaceutical Inc. | 078301063 | manufacture(17714-045) |